Impedimed device gets breakthrough designation for kidney failure
The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis.
The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis.
The startup, which leverages technology to assist chronic kidney disease and end-stage renal disease patients, has wrapped up a $24 million Series A round led by Oak HC/FT.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The study out of Vanderbilt University Medical Center found 14 percent of individuals with genetic variants impacting the kidney had kidney transplants and 10 percent with another variant had liver transplants. These transplants could have been avoided had the underlying genetic cause been disclosed.
Outset Medical just raised $60 million - and possibly more - to build out its at-home dialysis machine for patients with kidney failure.